Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the study record, signaling a minor metadata update. There are no visible changes to the study details or content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows the updated revision number (v3.6.4) replacing the previous v3.6.3, indicating a small release of the page rather than a change to study data.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page footer revision label was updated from v3.6.2 to v3.6.3, indicating a minor release update to the study page rendering.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision updated from v3.6.0 to v3.6.2. This indicates a minor internal update to the page metadata.SummaryDifference0.1%

- Check67 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a UI revision note (Revision: v3.6.0) were added, and the Intervention header formatting was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.5%

- Check75 days agoChange DetectedThe footer now shows a new revision label: v3.5.5, replacing the previous v3.5.4. This represents a minor update to the page version.SummaryDifference0.1%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.